Contact Us

SEC Filings

Investor Contacts

Andrea N. Flynn, Ph.D.
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 3211
U.S.: +1 650 496 2717

SEC Filings

Filing date	Form	Description	Filing Group	View
Jul 26, 2024	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001232524-24-000056.pdf 0001232524-24-000056.rtf 0001232524-24-000056.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Feb 23, 2009	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001193125-09-034320.pdf 0001193125-09-034320.rtf 0001193125-09-034320.xls
Aug 10, 2012	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001193125-12-348899.pdf 0001193125-12-348899.rtf 0001193125-12-348899.xls
Dec 20, 2013	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001193125-13-481242.pdf 0001193125-13-481242.rtf 0001193125-13-481242.xls
Apr 01, 2014	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001445305-14-001240.pdf 0001445305-14-001240.rtf 0001445305-14-001240.xls
Jun 01, 2016	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001193125-16-608925.pdf 0001193125-16-608925.rtf 0001193125-16-608925.xls
Sep 27, 2016	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001232524-16-000372.pdf 0001232524-16-000372.rtf 0001232524-16-000372.xls
Jul 19, 2021	8-K/A	Amendment to a previously filed 8-K	Current Reports	View HTML 0001193125-21-218588.pdf 0001193125-21-218588.rtf 0001193125-21-218588.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jan 18, 2012	8-K12B	8-K12B	Other	View HTML 0001193125-12-015521.pdf 0001193125-12-015521.rtf 0001193125-12-015521.xls
Apr 23, 2010	ARS	An annual report to security holders	Annual Filings	View HTML

Data provided by Kaleidoscope.